Category : Public Health, Disease Prevention & Wellness

Public Health, Disease Prevention & Wellness

Sensible Biotech Cuts Cell-Based mRNA Optimization Time 90%+ with AI

Business Wire
by Business Wire0140
https://bi-journal.com/creatopy-unveils-live-data-with-20-growth-boost/Sensible Biotechnologies, a biotechnology company pioneering a cell-based platform for the design and manufacturing of mRNA therapeutics, today announced an initiative to accelerate the development...
Public Health, Disease Prevention & Wellness

Avidity Reports Positive Phase 1/2 FSHD Data for Del-Brax

PR Newswire
by PR Newswire0134
— Unprecedented data from FORTITUDE™ dose escalation cohorts for del-brax treated participants, compared to placebo, demonstrate improvement in function, strength and PROs as well as rapid...
Public Health, Disease Prevention & Wellness

ERA Congress: Long-Term Data Show Zigakibart’s Efficacy in IgA Nephropathy

PR Newswire
by PR Newswire0139
New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy...
Public Health, Disease Prevention & Wellness

ISSA Launches GLP-1 Training for New Weight Loss Coaching Era

PR Newswire
by PR Newswire0179
The International Sports Sciences Association (ISSA) has announced the launch of its comprehensive GLP-1 Weight Loss Support Training, designed to equip personal trainers, health coaches, and fitness...
Public Health, Disease Prevention & Wellness

CE Health Interactive Launches Two CME Grant Programs

PR Newswire
by PR Newswire0169
CE Health Interactive proudly announces the launch of two groundbreaking Continuing Medical Education (CME) grant programs aimed at tackling gender and racial disparities in migraine...
Public Health, Disease Prevention & Wellness

TriLink BioTechnologies & IVI Sign MOU to Develop mRNA Vaccines

Business Wire
by Business Wire0211
TriLink BioTechnologies, a Maravai® LifeSciences company and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit international organization...
Public Health, Disease Prevention & Wellness

NEJM Publishes Phase 2b Data on Oveporexton for Narcolepsy

Business Wire
by Business Wire0204
–Data Demonstrated Statistically Significant Improvements in Primary and Secondary Endpoints with Most Subjects Achieving Near Normal Ranges of Wakefulness and Clinically Meaningful Improvements Across the Broad...